 Roy Morello
Concepts (185)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteogenesis Imperfecta | 13 | 2022 | 37 | 4.070 |
Why?
| | Collagen Type I | 6 | 2022 | 81 | 2.150 |
Why?
| | Extracellular Matrix Proteins | 9 | 2020 | 68 | 1.810 |
Why?
| | Bone and Bones | 9 | 2021 | 481 | 1.700 |
Why?
| | Molecular Chaperones | 9 | 2020 | 59 | 1.260 |
Why?
| | Autoantigens | 3 | 2017 | 49 | 1.070 |
Why?
| | Mutation | 11 | 2022 | 1280 | 1.050 |
Why?
| | Collagen | 6 | 2022 | 204 | 0.960 |
Why?
| | Endoplasmic Reticulum | 3 | 2017 | 117 | 0.930 |
Why?
| | Procollagen-Proline Dioxygenase | 3 | 2017 | 9 | 0.920 |
Why?
| | Ehlers-Danlos Syndrome | 2 | 2022 | 6 | 0.910 |
Why?
| | Disease Models, Animal | 6 | 2022 | 1440 | 0.860 |
Why?
| | Protein Processing, Post-Translational | 5 | 2020 | 156 | 0.780 |
Why?
| | Proteins | 5 | 2018 | 343 | 0.760 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 97 | 0.720 |
Why?
| | Mice | 18 | 2023 | 5677 | 0.720 |
Why?
| | Endocrinology | 1 | 2020 | 11 | 0.700 |
Why?
| | Gene Expression | 2 | 2021 | 610 | 0.690 |
Why?
| | Osteocytes | 1 | 2021 | 225 | 0.610 |
Why?
| | Gene Targeting | 1 | 2018 | 29 | 0.600 |
Why?
| | Rare Diseases | 1 | 2018 | 43 | 0.590 |
Why?
| | Animals | 19 | 2023 | 13157 | 0.580 |
Why?
| | Bone Diseases | 1 | 2018 | 96 | 0.550 |
Why?
| | Mice, Knockout | 8 | 2023 | 842 | 0.530 |
Why?
| | Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.520 |
Why?
| | Homeostasis | 3 | 2023 | 204 | 0.470 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2010 | 135 | 0.420 |
Why?
| | Lung | 3 | 2022 | 507 | 0.360 |
Why?
| | Hydroxylation | 4 | 2017 | 61 | 0.360 |
Why?
| | Mice, Inbred C57BL | 8 | 2020 | 1801 | 0.350 |
Why?
| | Connective Tissue Diseases | 1 | 2010 | 17 | 0.340 |
Why?
| | Cells, Cultured | 4 | 2020 | 1578 | 0.330 |
Why?
| | Bone Development | 1 | 2010 | 66 | 0.330 |
Why?
| | Syndactyly | 1 | 2008 | 4 | 0.310 |
Why?
| | Extremities | 1 | 2008 | 30 | 0.300 |
Why?
| | Cartilage | 1 | 2008 | 47 | 0.300 |
Why?
| | DNA | 1 | 2010 | 536 | 0.270 |
Why?
| | Osteogenesis | 3 | 2020 | 355 | 0.270 |
Why?
| | Extracellular Matrix | 2 | 2018 | 109 | 0.260 |
Why?
| | Membrane Proteins | 1 | 2008 | 341 | 0.260 |
Why?
| | Energy Metabolism | 2 | 2023 | 286 | 0.250 |
Why?
| | X-Ray Microtomography | 2 | 2022 | 80 | 0.240 |
Why?
| | Humans | 19 | 2023 | 50688 | 0.230 |
Why?
| | NAD | 1 | 2023 | 41 | 0.210 |
Why?
| | Relaxin | 1 | 2022 | 2 | 0.200 |
Why?
| | Collagen Type V | 1 | 2022 | 4 | 0.200 |
Why?
| | Haploinsufficiency | 1 | 2022 | 14 | 0.200 |
Why?
| | Proteoglycans | 2 | 2014 | 81 | 0.180 |
Why?
| | Cyclophilins | 3 | 2016 | 9 | 0.180 |
Why?
| | Calcification, Physiologic | 2 | 2020 | 40 | 0.180 |
Why?
| | Membrane Glycoproteins | 2 | 2014 | 246 | 0.170 |
Why?
| | Craniofacial Abnormalities | 1 | 2020 | 27 | 0.170 |
Why?
| | Mice, Transgenic | 3 | 2018 | 540 | 0.160 |
Why?
| | Fractures, Bone | 1 | 2020 | 110 | 0.160 |
Why?
| | Transcriptome | 1 | 2021 | 314 | 0.160 |
Why?
| | Male | 10 | 2022 | 25998 | 0.150 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2018 | 7 | 0.150 |
Why?
| | Osteitis Deformans | 1 | 2018 | 4 | 0.150 |
Why?
| | Calcium, Dietary | 1 | 2018 | 13 | 0.150 |
Why?
| | Gene-Environment Interaction | 1 | 2018 | 36 | 0.150 |
Why?
| | DNA Breaks, Double-Stranded | 1 | 2018 | 65 | 0.150 |
Why?
| | Fibroblasts | 3 | 2010 | 340 | 0.150 |
Why?
| | Metabolic Networks and Pathways | 1 | 2018 | 92 | 0.140 |
Why?
| | Rabbits | 1 | 2018 | 372 | 0.140 |
Why?
| | Molecular Targeted Therapy | 1 | 2018 | 122 | 0.140 |
Why?
| | Testis | 2 | 2022 | 66 | 0.130 |
Why?
| | Pelvis | 1 | 2017 | 66 | 0.130 |
Why?
| | Calcium | 1 | 2018 | 399 | 0.130 |
Why?
| | Lysine | 1 | 2017 | 84 | 0.130 |
Why?
| | Chondrocytes | 2 | 2008 | 40 | 0.130 |
Why?
| | Virulence | 1 | 2016 | 168 | 0.120 |
Why?
| | Virulence Factors | 1 | 2016 | 78 | 0.120 |
Why?
| | DNA Mutational Analysis | 4 | 2011 | 175 | 0.120 |
Why?
| | Female | 6 | 2022 | 27188 | 0.120 |
Why?
| | Genetic Predisposition to Disease | 1 | 2018 | 511 | 0.120 |
Why?
| | Osteomyelitis | 1 | 2016 | 128 | 0.120 |
Why?
| | Cell Line | 2 | 2016 | 1001 | 0.120 |
Why?
| | Mice, Mutant Strains | 1 | 2014 | 69 | 0.110 |
Why?
| | Organ Size | 1 | 2014 | 225 | 0.110 |
Why?
| | Polymerase Chain Reaction | 3 | 2010 | 451 | 0.110 |
Why?
| | Insulin | 2 | 2022 | 465 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2016 | 367 | 0.100 |
Why?
| | Staphylococcus aureus | 1 | 2016 | 323 | 0.100 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 782 | 0.100 |
Why?
| | In Situ Hybridization | 2 | 2010 | 66 | 0.100 |
Why?
| | Skin | 2 | 2017 | 385 | 0.100 |
Why?
| | Serpins | 1 | 2011 | 5 | 0.100 |
Why?
| | Rats | 1 | 2018 | 3302 | 0.100 |
Why?
| | Nerve Growth Factors | 1 | 2011 | 28 | 0.090 |
Why?
| | Eye Proteins | 1 | 2011 | 17 | 0.090 |
Why?
| | Cell Respiration | 1 | 2010 | 41 | 0.090 |
Why?
| | Proline | 1 | 2010 | 30 | 0.090 |
Why?
| | Connective Tissue | 1 | 2010 | 23 | 0.090 |
Why?
| | Ascorbic Acid | 1 | 2010 | 21 | 0.080 |
Why?
| | Osteoporosis | 2 | 2010 | 156 | 0.080 |
Why?
| | Mitochondrial Proteins | 1 | 2010 | 87 | 0.080 |
Why?
| | Fluorescent Antibody Technique | 1 | 2010 | 109 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 578 | 0.080 |
Why?
| | Cell Proliferation | 2 | 2010 | 986 | 0.080 |
Why?
| | Tandem Mass Spectrometry | 1 | 2010 | 239 | 0.080 |
Why?
| | Chondrogenesis | 1 | 2008 | 11 | 0.080 |
Why?
| | Blotting, Northern | 1 | 2008 | 110 | 0.080 |
Why?
| | In Situ Nick-End Labeling | 1 | 2008 | 52 | 0.080 |
Why?
| | RNA, Messenger | 2 | 2010 | 1089 | 0.070 |
Why?
| | Mitochondria | 1 | 2010 | 400 | 0.070 |
Why?
| | Fibrillar Collagens | 1 | 2006 | 2 | 0.070 |
Why?
| | Osteochondrodysplasias | 1 | 2006 | 12 | 0.070 |
Why?
| | Bone Diseases, Metabolic | 1 | 2006 | 74 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2008 | 643 | 0.060 |
Why?
| | Kidney | 1 | 2010 | 694 | 0.060 |
Why?
| | Osteoclasts | 2 | 2020 | 427 | 0.060 |
Why?
| | Collagen Type X | 1 | 2003 | 3 | 0.050 |
Why?
| | Apoptosis | 1 | 2008 | 1098 | 0.050 |
Why?
| | Receptors, Peptide | 1 | 2022 | 10 | 0.050 |
Why?
| | Gonadal Steroid Hormones | 1 | 2022 | 41 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2022 | 49 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2020 | 958 | 0.050 |
Why?
| | Multiple Myeloma | 1 | 2017 | 2994 | 0.050 |
Why?
| | Oxidation-Reduction | 1 | 2023 | 315 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2003 | 321 | 0.050 |
Why?
| | Osteoblasts | 2 | 2016 | 463 | 0.040 |
Why?
| | Periodontal Ligament | 1 | 2020 | 3 | 0.040 |
Why?
| | Time Factors | 1 | 2006 | 2948 | 0.040 |
Why?
| | Cytokines | 1 | 2023 | 607 | 0.040 |
Why?
| | Adult | 4 | 2022 | 13637 | 0.040 |
Why?
| | Transcription Factors | 1 | 2003 | 566 | 0.040 |
Why?
| | Skull | 1 | 2020 | 77 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2003 | 952 | 0.040 |
Why?
| | Infant, Newborn | 3 | 2011 | 2760 | 0.040 |
Why?
| | Dentin | 1 | 2017 | 6 | 0.030 |
Why?
| | Phenotype | 1 | 2020 | 739 | 0.030 |
Why?
| | Cross-Linking Reagents | 1 | 2017 | 41 | 0.030 |
Why?
| | Cornea | 1 | 2017 | 51 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2017 | 94 | 0.030 |
Why?
| | Operon | 1 | 2016 | 28 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 151 | 0.030 |
Why?
| | Aorta | 1 | 2017 | 163 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2017 | 232 | 0.030 |
Why?
| | Mass Spectrometry | 1 | 2017 | 285 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2016 | 188 | 0.030 |
Why?
| | Skeleton | 1 | 2014 | 1 | 0.030 |
Why?
| | Gene Knock-In Techniques | 1 | 2014 | 23 | 0.030 |
Why?
| | Protein Interaction Maps | 1 | 2014 | 22 | 0.030 |
Why?
| | Protein Folding | 1 | 2014 | 45 | 0.030 |
Why?
| | Proteomics | 1 | 2016 | 317 | 0.030 |
Why?
| | Staphylococcal Infections | 1 | 2016 | 267 | 0.030 |
Why?
| | Pedigree | 1 | 2011 | 119 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2017 | 1169 | 0.020 |
Why?
| | Spermatocytes | 1 | 2010 | 3 | 0.020 |
Why?
| | Spermatids | 1 | 2010 | 3 | 0.020 |
Why?
| | Sertoli Cells | 1 | 2010 | 3 | 0.020 |
Why?
| | Leydig Cells | 1 | 2010 | 7 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 644 | 0.020 |
Why?
| | RNA Interference | 1 | 2010 | 179 | 0.020 |
Why?
| | Flavonoids | 1 | 2010 | 41 | 0.020 |
Why?
| | HeLa Cells | 1 | 2010 | 257 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 356 | 0.020 |
Why?
| | Stilbenes | 1 | 2010 | 52 | 0.020 |
Why?
| | Phylogeny | 1 | 2010 | 237 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2010 | 192 | 0.020 |
Why?
| | Adenosine Triphosphate | 1 | 2010 | 232 | 0.020 |
Why?
| | Consanguinity | 1 | 2008 | 17 | 0.020 |
Why?
| | Antioxidants | 1 | 2010 | 239 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2011 | 1199 | 0.020 |
Why?
| | Prenatal Diagnosis | 1 | 2008 | 97 | 0.020 |
Why?
| | Plant Extracts | 1 | 2010 | 175 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 155 | 0.020 |
Why?
| | Genes, Recessive | 1 | 2006 | 15 | 0.020 |
Why?
| | Models, Biological | 1 | 2010 | 721 | 0.020 |
Why?
| | Radiography | 1 | 2006 | 486 | 0.020 |
Why?
| | Ultrasonography, Prenatal | 1 | 2006 | 160 | 0.010 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2003 | 44 | 0.010 |
Why?
| | Humerus | 1 | 2003 | 18 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 64 | 0.010 |
Why?
| | Hypertrophy | 1 | 2003 | 50 | 0.010 |
Why?
| | Aged | 1 | 2017 | 9770 | 0.010 |
Why?
| | Infant | 1 | 2011 | 3660 | 0.010 |
Why?
| | Child, Preschool | 1 | 2011 | 3966 | 0.010 |
Why?
| | Femur | 1 | 2003 | 130 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 365 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2003 | 362 | 0.010 |
Why?
| | Middle Aged | 1 | 2017 | 12648 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2003 | 463 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 6489 | 0.010 |
Why?
| | Child | 1 | 2011 | 6979 | 0.010 |
Why?
|
|
Morello's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|